89 percent of patients evaluable for MRD assessment were MRD negative, with the majority reaching MRD negativity in less than 2 months Results add to the overall survival (OS) benefits… Read More
LAVAL, QC – Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals (“Salix”), alongside the U.S. Pain Foundation (USPF), the International Foundation for Gastrointestinal Disorders (IFFGD), and… Read More
Data presented at the 66th Annual Meeting and Exposition of the American Society of Hematology (ASH) NORTH CHICAGO, ILL – AbbVie (NYSE: ABBV) announced new results from two ongoing clinical trials… Read More
Tavapadon met the primary endpoint in the pivotal Phase 3 TEMPO-2 flexible-dose monotherapy trial, demonstrating a statistically significant improvement from baseline in the MDS-UPDRS Parts II and III combined score… Read More
The Legal 500 Canada has recognized Mintz in its 2025 guide of the best Canadian firms and lawyers practicing within the Canadian market, based on extensive research conducted by the directory over… Read More
